5 Einträge gefunden

1. Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment:A Phase 3 Randomized Clinical Trial

   1. Friedl, Thomas W P
   2. Fehm, Tanja
   3. Müller, Volkmar
   4. Lichtenegger, Werner
   5. Blohmer, Jens
   6. Lorenz, Ralf
   7. Forstbauer, Helmut

   2021 - Forschungsinformationssystem des UKE
2. Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients.

   1. Sehouli, Jalid
   2. Richter, R
   3. Braicu, Elena Ioana
   4. Bühling, Kai J.
   5. Bahra, Marcus
   6. Neuhaus, Peter
   7. Lichtenegger, Werner

   2010 - Forschungsinformationssystem des UKE
3. A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer.

   1. Sehouli, Jalid
   2. Camara, Oumar
   3. Mahner, Sven
   4. Bauknecht, Thomas
   5. Lichtenegger, Werner
   6. Runnebaum, Ingo
   7. Look, Katherine

   2010 - Forschungsinformationssystem des UKE
4. Prognostic Value of Serum and Ascites Levels of Estradiol, FSH, LH and Prolactin in Ovarian Cancer.

   1. Chen, Frank Chih-Kang
   2. Oskay-Ozcelik, Guelten
   3. Bühling, Kai J.
   4. Köpstein, Uta
   5. Mentze, Monika
   6. Lichtenegger, Werner
   7. Sehouli, Jalid

   2009 - Forschungsinformationssystem des UKE
5. Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: a phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy.

   1. Krainick-Strobel, Ute E
   2. Lichtenegger, Werner
   3. Wallwiener, Diethelm
   4. Tulusan, Augustinus H
   5. Jänicke, Fritz
   6. Bastert, Gunther
   7. Kiesel, Ludwig

   2008 - Forschungsinformationssystem des UKE - frei zugänglich